Nurudeen Mahama, NP
Adult Health · Yuma, AZNPI 1992782007
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,054 of the $4,233 with a category attached, or 72.2%. 17 manufacturers reported payments, led by Medtronic at 34.9% of the total. 2025 is the largest year on record at $2,869, 4.0 times the $719 reported in 2023. Among adult health clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 95 payments — averaging $44.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- AstraZeneca$474
- Bayer$430
- Ardelyx, Inc.$304
- Akebia Therapeutics Inc$271
- OPKO Pharmaceuticals, LLC$249
- plus $1K from 11 others
What the payments were for
- Travel & lodging$1,17928%
- Food & beverage$3,05472%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 10 | $1,478 |
| AstraZeneca | 18 | $474 |
| Bayer | 20 | $430 |
| Ardelyx, Inc. | 7 | $304 |
| Akebia Therapeutics Inc | 3 | $271 |
| OPKO Pharmaceuticals, LLC | 12 | $249 |
| Travere Therapeutics, Inc. | 3 | $200 |
| Calliditas Therapeutics US Inc. | 3 | $173 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $158 |
| Novartis | 6 | $137 |
| Mallinckrodt Hospital Products Inc. | 2 | $95 |
| Boston Scientific | 1 | $64 |
| Fresenius USA Marketing, Inc. | 3 | $56 |
| Amgen | 3 | $56 |
| Kyowa Kirin, Inc. | 1 | $50 |
| Boehringer Ingelheim | 1 | $22 |
| Vifor Pharma, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYMPLICITY G3$1,238
- Vafseo$247
- FARXIGA$125
- Filspari$125
- TARPEYO$125
- Kerendia$124
- XPHOZAH 30 MG$124
How this compares
$4,233 in reported general payments places this provider in the 90th percentile of 314 adult health providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LokelmaSodium Zirconium Cyclosilicate | 184 | $181,970 |
| Sevelamer Hcl | 41 | $82,201 |
| FarxigaDapagliflozin Propanediol | 79 | $73,875 |
| JardianceEmpagliflozin | 43 | $45,606 |
| VeltassaPatiromer Calcium Sorbitex | 21 | $32,877 |
| Calcium Acetate | 90 | $8,532 |
| Sevelamer Carbonate | 21 | $7,417 |
| Calcitriol | 256 | $4,728 |
| Bumetanide | 125 | $4,291 |
| Hydralazine Hcl | 172 | $3,372 |
| Midodrine Hcl | 49 | $2,943 |
| Losartan Potassium | 153 | $2,826 |
| Estradiol | 35 | $2,671 |
| Amlodipine Besylate | 213 | $2,379 |
| Nifedipine ErNifedipine | 43 | $1,766 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaLokelma, Farxiga | $474 | $255,845263 claims |
| Boehringer IngelheimJardiance | $22 | $45,60643 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 314 adult health providers in Arizona.
Other adult health in Yuma
- Luz WileyYuma$3K
- Lauren MohamedYuma$2K
- Therese SargentPhoenix$307K
- Heather McCoyScottsdale$156K
- Jennifer MylodGlendale$131K
- Natalie WilsonPhoenix$94K
- Amy KleinhansMesa$60K
- Michelle TaylorGilbert$36K
- Sherry DentonScottsdale$23K
- Kristin StaniszewskiPhoenix$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.